Filtros : "Chemical Biology and Drug Design" Limpar

Filtros



Refine with date range


  • Source: Chemical Biology and Drug Design. Unidade: IFSC

    Subjects: LEISHMANIA, MECANISMOS DE DEFESA, TRYPANOSOMA CRUZI

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LAPIERRE, Thibault Joseph William Jacques Dit et al. Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum. Chemical Biology and Drug Design, v. 103, p. e14525-1-e14525-14 + supporting information, 2024Tradução . . Disponível em: https://doi.org/10.1111/cbdd.14525. Acesso em: 05 nov. 2024.
    • APA

      Lapierre, T. J. W. J. D., Farago, D. N., Cruz, M. G. F. de M. L., Resende, D. de M., Oliveira, A. C. R. de, Santos, B. R. M. dos, et al. (2024). Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum. Chemical Biology and Drug Design, 103, e14525-1-e14525-14 + supporting information. doi:10.1111/cbdd.14525
    • NLM

      Lapierre TJWJD, Farago DN, Cruz MGF de ML, Resende D de M, Oliveira ACR de, Santos BRM dos, Souza F de O, Duarte SM, Chelucci RC, Andricopulo AD, Ferreira LLG, Pilau EJ, Murta SMF, Rezende Junior C de O. Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum [Internet]. Chemical Biology and Drug Design. 2024 ; 103 e14525-1-e14525-14 + supporting information.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.14525
    • Vancouver

      Lapierre TJWJD, Farago DN, Cruz MGF de ML, Resende D de M, Oliveira ACR de, Santos BRM dos, Souza F de O, Duarte SM, Chelucci RC, Andricopulo AD, Ferreira LLG, Pilau EJ, Murta SMF, Rezende Junior C de O. Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum [Internet]. Chemical Biology and Drug Design. 2024 ; 103 e14525-1-e14525-14 + supporting information.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.14525
  • Source: Chemical Biology and Drug Design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    PrivadoAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MELANDER, Roberta e MONTANARI, Carlos Alberto. Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html. Acesso em: 05 nov. 2024. , 2023
    • APA

      Melander, R., & Montanari, C. A. (2023). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • NLM

      Melander R, Montanari CA. Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2023 ;[citado 2024 nov. 05 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • Vancouver

      Melander R, Montanari CA. Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2023 ;[citado 2024 nov. 05 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
  • Source: Chemical Biology and Drug Design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    PrivadoAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html. Acesso em: 05 nov. 2024. , 2022
    • APA

      Chemical Biology and Drug Design. (2022). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • NLM

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2022 ;[citado 2024 nov. 05 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • Vancouver

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2022 ;[citado 2024 nov. 05 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
  • Source: Chemical Biology and Drug Design. Unidades: IQ, FCFRP

    Subjects: FITOQUÍMICA, ANTIPROTOZOÁRIOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TREFZGER, Ozildeia S et al. Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G. Chemical Biology and Drug Design, v. 93, n. 3, p. 313-324, 2019Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13417. Acesso em: 05 nov. 2024.
    • APA

      Trefzger, O. S., Neves, A. R. das, Barbosa, N. V., Carvalho, D. B., Pereira, I. C., Perdomo, R. T., et al. (2019). Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G. Chemical Biology and Drug Design, 93( 3), 313-324. doi:10.1111/cbdd.13417
    • NLM

      Trefzger OS, Neves AR das, Barbosa NV, Carvalho DB, Pereira IC, Perdomo RT, Matos MFC, Yoshida NC, Kato MJ, Albuquerque S de, Arruda CCP, Baroni ACM. Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G [Internet]. Chemical Biology and Drug Design. 2019 ; 93( 3): 313-324.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.13417
    • Vancouver

      Trefzger OS, Neves AR das, Barbosa NV, Carvalho DB, Pereira IC, Perdomo RT, Matos MFC, Yoshida NC, Kato MJ, Albuquerque S de, Arruda CCP, Baroni ACM. Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G [Internet]. Chemical Biology and Drug Design. 2019 ; 93( 3): 313-324.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.13417
  • Source: Chemical Biology and Drug Design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    PrivadoHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf. Acesso em: 05 nov. 2024. , 2019
    • APA

      Chemical Biology and Drug Design. (2019). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
    • NLM

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2019 ;[citado 2024 nov. 05 ] Available from: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
    • Vancouver

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2019 ;[citado 2024 nov. 05 ] Available from: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
  • Source: Chemical Biology and Drug Design. Unidades: FCF, ICB

    Subjects: PLASMODIUM FALCIPARUM, PARASITOLOGIA, MALÁRIA, QUIMIOTERAPIA, ENZIMAS PROTEOLITICAS, ATIVAÇÃO ENZIMÁTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MEISSNER, Kamila Anna et al. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, v. 2018 p. 1-13, 2018Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13416. Acesso em: 05 nov. 2024.
    • APA

      Meissner, K. A., Kronenberger, T., Maltarollo, V. G., Trossini, G. H. G., & Wrenger, C. (2018). Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, 2018 p. 1-13. doi:10.1111/cbdd.13416
    • NLM

      Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.13416
    • Vancouver

      Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.13416
  • Source: Chemical Biology and Drug Design. Unidade: EACH

    Subjects: DOENÇA DE CHAGAS, QUÍMICA MÉDICA, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SARAIVA, Ádria P. B. et al. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics. Chemical Biology and Drug Design, p. 01-13, 2018Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13313. Acesso em: 05 nov. 2024.
    • APA

      Saraiva, Á. P. B., Miranda, R. M., Valente, R. P. P., Araújo, J. O., Souza, R. N. B., Costa, C. H. S., et al. (2018). Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics. Chemical Biology and Drug Design, 01-13. doi:10.1111/cbdd.13313
    • NLM

      Saraiva ÁPB, Miranda RM, Valente RPP, Araújo JO, Souza RNB, Costa CHS, Oliveira ARS, Almeida MO, Figueiredo AF, Ferreira JEV, Alves CN, Honorio KM. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics [Internet]. Chemical Biology and Drug Design. 2018 ; 01-13.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.13313
    • Vancouver

      Saraiva ÁPB, Miranda RM, Valente RPP, Araújo JO, Souza RNB, Costa CHS, Oliveira ARS, Almeida MO, Figueiredo AF, Ferreira JEV, Alves CN, Honorio KM. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics [Internet]. Chemical Biology and Drug Design. 2018 ; 01-13.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.13313
  • Source: Chemical Biology and Drug Design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    Versão PublicadaHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Wiley-Blackwell Publishing, Inc. Disponível em: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf. Acesso em: 05 nov. 2024. , 2017
    • APA

      Chemical Biology and Drug Design. (2017). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Wiley-Blackwell Publishing, Inc. Recuperado de https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf
    • NLM

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2017 ;[citado 2024 nov. 05 ] Available from: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf
    • Vancouver

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2017 ;[citado 2024 nov. 05 ] Available from: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf
  • Source: Chemical Biology and Drug Design. Unidade: EACH

    Subjects: PORFIRINAS, QUÍMICA QUÂNTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BETTANIN, Fernanda et al. Quantum-chemistry descriptors for photosensitizers based on macrocycles. Chemical Biology and Drug Design, v. 89, n. 2, p. 207-220, 2017Tradução . . Disponível em: https://doi.org/10.1111/cbdd.12791. Acesso em: 05 nov. 2024.
    • APA

      Bettanin, F., Antonio, F. C. T., Honório, K. M., & Homem-de-Mello, P. (2017). Quantum-chemistry descriptors for photosensitizers based on macrocycles. Chemical Biology and Drug Design, 89( 2), 207-220. doi:10.1111/cbdd.12791
    • NLM

      Bettanin F, Antonio FCT, Honório KM, Homem-de-Mello P. Quantum-chemistry descriptors for photosensitizers based on macrocycles [Internet]. Chemical Biology and Drug Design. 2017 ; 89( 2): 207-220.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.12791
    • Vancouver

      Bettanin F, Antonio FCT, Honório KM, Homem-de-Mello P. Quantum-chemistry descriptors for photosensitizers based on macrocycles [Internet]. Chemical Biology and Drug Design. 2017 ; 89( 2): 207-220.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.12791
  • Source: Chemical Biology and Drug Design. Unidade: FCF

    Subjects: PLANEJAMENTO DE FÁRMACOS, DOENÇAS NEGLIGENCIADAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MELLO, Juliana da Fonseca Rezende e et al. Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases. Chemical Biology and Drug Design, v. 90, n. 6. p. 1067-1078, 2017Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13030. Acesso em: 05 nov. 2024.
    • APA

      Mello, J. da F. R. e, Gomes, R. A., Fujii, D. G. V., Ferreira, G. M., & Trossini, G. H. G. (2017). Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases. Chemical Biology and Drug Design, 90( 6. p. 1067-1078). doi:10.1111/cbdd.13030
    • NLM

      Mello J da FR e, Gomes RA, Fujii DGV, Ferreira GM, Trossini GHG. Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases [Internet]. Chemical Biology and Drug Design. 2017 ; 90( 6. p. 1067-1078):[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.13030
    • Vancouver

      Mello J da FR e, Gomes RA, Fujii DGV, Ferreira GM, Trossini GHG. Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases [Internet]. Chemical Biology and Drug Design. 2017 ; 90( 6. p. 1067-1078):[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.13030
  • Source: Chemical Biology and Drug Design. Unidade: EACH

    Subjects: RELAÇÕES ESTRUTURA-ATIVIDADE, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, PEPTÍDEOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GUERRA, Mirian Elisa Rodrigues et al. MD simulations and multivariate studies for modeling the antileishmanial activity of peptides. Chemical Biology and Drug Design, p. 1-10, 2017Tradução . . Disponível em: https://doi.org/10.1111/cbdd.12970. Acesso em: 05 nov. 2024.
    • APA

      Guerra, M. E. R., Fadel, V., Maltarollo, V. G., Baldissera, G., Honório, K. M., Ruggiero, J. R., & Cabrera, M. P. dos S. (2017). MD simulations and multivariate studies for modeling the antileishmanial activity of peptides. Chemical Biology and Drug Design, 1-10. doi:10.1111/cbdd.12970
    • NLM

      Guerra MER, Fadel V, Maltarollo VG, Baldissera G, Honório KM, Ruggiero JR, Cabrera MP dos S. MD simulations and multivariate studies for modeling the antileishmanial activity of peptides [Internet]. Chemical Biology and Drug Design. 2017 ; 1-10.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.12970
    • Vancouver

      Guerra MER, Fadel V, Maltarollo VG, Baldissera G, Honório KM, Ruggiero JR, Cabrera MP dos S. MD simulations and multivariate studies for modeling the antileishmanial activity of peptides [Internet]. Chemical Biology and Drug Design. 2017 ; 1-10.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.12970
  • Source: Chemical Biology and Drug Design. Unidades: FCFRP, FMRP

    Subjects: LEISHMANIA BRASILIENSIS, ANTIPROTOZOÁRIOS, PLANEJAMENTO DE FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TOLEDO, Juliano S. de et al. Synthesis, cytotoxicity and in vitro antileishmanial activity of naphthothiazoles. Chemical Biology and Drug Design, v. 81, n. 6, p. 749-756, 2013Tradução . . Disponível em: https://doi.org/10.1111/cbdd.12123. Acesso em: 05 nov. 2024.
    • APA

      Toledo, J. S. de, Júnior, P. E. S., Manfrim, V., Pinzan, C. F., Araújo, A. S. de, Cruz, Â. K., & Emery, F. da S. (2013). Synthesis, cytotoxicity and in vitro antileishmanial activity of naphthothiazoles. Chemical Biology and Drug Design, 81( 6), 749-756. doi:10.1111/cbdd.12123
    • NLM

      Toledo JS de, Júnior PES, Manfrim V, Pinzan CF, Araújo AS de, Cruz ÂK, Emery F da S. Synthesis, cytotoxicity and in vitro antileishmanial activity of naphthothiazoles [Internet]. Chemical Biology and Drug Design. 2013 ; 81( 6): 749-756.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.12123
    • Vancouver

      Toledo JS de, Júnior PES, Manfrim V, Pinzan CF, Araújo AS de, Cruz ÂK, Emery F da S. Synthesis, cytotoxicity and in vitro antileishmanial activity of naphthothiazoles [Internet]. Chemical Biology and Drug Design. 2013 ; 81( 6): 749-756.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/cbdd.12123
  • Source: Chemical Biology and Drug Design. Unidade: EACH

    Subjects: MODELAGEM MOLECULAR, QUÍMICA QUÂNTICA, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MALTAROLLO, Vinícius Gonçalves e HONÓRIO, Kathia Maria. Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity. Chemical Biology and Drug Design, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1747-0285.2012.01424.x. Acesso em: 05 nov. 2024.
    • APA

      Maltarollo, V. G., & Honório, K. M. (2012). Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity. Chemical Biology and Drug Design. doi:10.1111/j.1747-0285.2012.01424.x
    • NLM

      Maltarollo VG, Honório KM. Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity [Internet]. Chemical Biology and Drug Design. 2012 ;[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/j.1747-0285.2012.01424.x
    • Vancouver

      Maltarollo VG, Honório KM. Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity [Internet]. Chemical Biology and Drug Design. 2012 ;[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/j.1747-0285.2012.01424.x

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024